Literature DB >> 29715479

High-Throughput In-Use and Stress Size Stability Screening of Protein Therapeutics Using Algorithm-Driven Dynamic Light Scattering.

Ashwinkumar A Bhirde1, Meng-Jung Chiang2, Ramesh Venna2, Serge Beaucage2, Kurt Brorson2.   

Abstract

Stability of therapeutic proteins (TPs) is a critical quality attribute that impacts both safety and efficacy of the drug. Size stability is routinely performed during and after biomanufacturing. Dynamic light scattering (DLS) is a commonly used technique to characterize hydrodynamic size of the TPs. Herein, we have developed a novel method to evaluate in-use and thermal stress stability of TPs using algorithm-driven high-throughput DLS. Five marketed TPs were tested under the guidance of customized algorithms. The TPs were evaluated at relevant temperature conditions as well as under dilution and thermal stress for size stability. We found that the TPs were stable under the in-use conditions tested; however, sample loss due to evaporation can lead to large protein aggregates. A combined assessment of autocorrelation function and photos of sample well could be useful in formulation screening. Dilution of TPs also has an impact on the hydrodynamic size. Thermal stress experiments showed the importance of using different data processing methods to access size distribution. Polydispersity index was useful in evaluating sample heterogeneity. Herein, we show that algorithm-driven high-throughput DLS can provide additional supportive information during and after biomanufacturing and the potential to be used in a quality control environment.
Copyright © 2018. Published by Elsevier Inc.

Keywords:  aggregates; algorithm; high-throughput dynamic light scattering; in-use stability; particles; particulates; quality control; stress stability; therapeutic proteins

Mesh:

Substances:

Year:  2018        PMID: 29715479     DOI: 10.1016/j.xphs.2018.04.017

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life Cycle.

Authors:  Roman Mathaes; Linda Narhi; Andrea Hawe; Anja Matter; Karoline Bechtold-Peters; Sophia Kenrick; Sambit Kar; Olga Laskina; John Carpenter; Richard Cavicchi; Ellen Koepf; E Neil Lewis; Rukman De Silva; Dean Ripple
Journal:  AAPS J       Date:  2019-10-30       Impact factor: 4.009

2.  Measuring Protein Aggregation and Stability Using High-Throughput Biophysical Approaches.

Authors:  Tristan O C Kwan; Stefan A Kolek; Amy E Danson; Rosana I Reis; Ines S Camacho; Patrick D Shaw Stewart; Isabel Moraes
Journal:  Front Mol Biosci       Date:  2022-05-16

3.  The ELISA Detectability and Potency of Pegfilgrastim Decrease in Physiological Conditions: Key Roles for Aggregation and Individual Variability.

Authors:  Tao Xie; Hui Fang; Weiming Ouyang; Phillip Angart; Meng-Jung Chiang; Ashwinkumar A Bhirde; Faruk Sheikh; Patrick Lynch; Ankit B Shah; Sharadrao M Patil; Kang Chen; Meiyu Shen; Cyrus Agarabi; Raymond P Donnelly; Kurt Brorson; Sarah J Schrieber; Kristina E Howard; Sarah M Rogstad; David M Frucht
Journal:  Sci Rep       Date:  2020-02-12       Impact factor: 4.379

4.  The uniqueness of flow in probing the aggregation behavior of clinically relevant antibodies.

Authors:  Leon F Willis; Amit Kumar; Tushar Jain; Isabelle Caffry; Yingda Xu; Sheena E Radford; Nikil Kapur; Maximiliano Vásquez; David J Brockwell
Journal:  Eng Rep       Date:  2020-03-15

5.  Optical and structural properties of Sn and Ag-doped PbS/PVA nanocomposites synthesized by chemical bath deposition.

Authors:  Ali Fatemi; Milad Rasouli; Tavakkol Tohidi; Kazem Jamshidi-Galeh; Kostya Ostrikov
Journal:  Sci Rep       Date:  2022-07-28       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.